A prospective study of continuous hepatic perfusion with implantable pump.
The delivery of chemotherapy through the implantable hepatic infusion pump in the management of patients with hepatic metastases secondary to carcinoma of the colon and rectum is evaluated in this preliminary prospective study. Patients were selected according to hepatic lobar distribution and magnitude, age, and general systemic evaluation. Infusion pumps were implanted in a total of 14 patients who were judged to be unsuitable for hepatic resection. After pump implantation all patients were alive and well and receiving regional perfusion chemotherapy. For the nine patients in this study who have been monitored for a full six months, the median decrease in CEA levels was 49 percent. On computerized axial tomography (CT) and/or liver-spleen scan, five patients showed greater than 50 percent reduction in tumor size. All patients have demonstrated minimal systemic toxicity and have maintained a good quality of life. The results encourage further evaluation of perfusion chemotherapy.
Riether
R D
RD
Khubchandani
I T
IT
Sheets
J A
JA
Stasik
J J
JJ
Rosen
L
L
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000295:instrumentation*; D003110:Colonic Neoplasms / Q000032:analysis / Q000601:surgery; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012004:Rectal Neoplasms / Q000032:analysis / Q000601:surgery
D002272:Carcinoembryonic Antigen; D005467:Floxuridine